Literature DB >> 3045123

Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions.

R Vogel1, I Assfalg-Machleidt, A Esterl, W Machleidt, W Müller-Esterl.   

Abstract

Low molecular weight kininogen from human plasma was subjected to limited proteolysis with trypsin, chymotrypsin, elastase, and bromelain, and the resulting fragments of 20,000 or 40,000 Da were isolated. Amino-terminal sequence analysis of the fragments disclosed for the various proteinases eight independent cleavage sites distinct from the typical kallikrein cleavage sites flanking the kinin region. All the identified cleavage sites cluster in two stretches of 11-12 residues of the kininogen heavy chain. These short segments represent the primary attack sites for proteinases ("proteinase-sensitive regions") in the heavy chain portion of human low molecular weight kininogen. The amino acid sequences of the two proteinase-sensitive regions are mutually homologous; they are further characterized by the presence of a single copy each of the consensus tetrapeptide Cys-X-Gly-Cys known to form a narrow disulfide loop (Kellermann, J., Thelen, C., Lottspeich, F., Henschen, A., Vogel, R., and Müller-Esterl, W. (1987) Biochem. J. 247, 15-21). The proteinase-sensitive regions are located at the junctions of the three cystatin-like domains constituting the kininogen heavy chain. Proteolytic cleavage at the sensitive regions dissects the kininogen heavy chain and releases single domains of 20,000 Da and combined domains of 40,000 Da which can function as cysteine proteinase inhibitors. The presence of kininogen heavy chain domains in plasma samples under pathologic conditions suggests that cleavage of the proteinase-sensitive regions might also occur in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045123

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Cleavage of plasma high molecular weight kininogen in surgical ICU patients.

Authors:  T S Karlsrud; L Buø; A O Aasen; H T Johansen
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

2.  High-affinity binding of two molecules of cysteine proteinases to low-molecular-weight kininogen.

Authors:  B Turk; V Stoka; I Björk; C Boudier; G Johansson; I Dolenc; A Colic; J G Bieth; V Turk
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

3.  Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin.

Authors:  M Haasemann; P Nawratil; W Müller-Esterl
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

4.  The contact system--a novel branch of innate immunity generating antibacterial peptides.

Authors:  Inga-Maria Frick; Per Akesson; Heiko Herwald; Matthias Mörgelin; Martin Malmsten; Dorit K Nägler; Lars Björck
Journal:  EMBO J       Date:  2006-11-09       Impact factor: 11.598

5.  Proteolysis of the 85-kilodalton crystalline cysteine proteinase inhibitor from potato releases functional cystatin domains.

Authors:  T A Walsh; J A Strickland
Journal:  Plant Physiol       Date:  1993-12       Impact factor: 8.340

6.  Characterization of a genomic sequence coding for potato multicystatin, an eight-domain cysteine proteinase inhibitor.

Authors:  C Waldron; L M Wegrich; P A Merlo; T A Walsh
Journal:  Plant Mol Biol       Date:  1993-11       Impact factor: 4.076

7.  Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum.

Authors:  J D Lonsdale-Eccles; G W Mpimbaza; Z R Nkhungulu; J Olobo; L Smith; O M Tosomba; D J Grab
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

8.  Streptococcal cysteine proteinase releases kinins: a virulence mechanism.

Authors:  H Herwald; M Collin; W Müller-Esterl; L Björck
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 9.  The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.

Authors:  Torsten G Loof; Christin Deicke; Eva Medina
Journal:  Front Cell Infect Microbiol       Date:  2014-09-11       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.